Market revenue in 2023 | USD 62.3 million |
Market revenue in 2030 | USD 295.4 million |
Growth rate | 24.9% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, NGS Commercial Software |
Key market players worldwide | Bio-Rad Laboratories Inc, DNAnexus, Qiagen NV, DNAstar, Pacific Biosciences of California Inc, Eurofins Scientific SE, Illumina Inc, PierianDx, Agilent Technologies Inc, Roche Holding AG, Alphabet Inc Class A, Thermo Fisher Scientific Inc, Golden Helix, Scigenom Labs, Genuity Science, Fabric Genomics (formerly Omicia), Congenica, Precigen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to next-generation sequencing data analysis market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 54.25% in 2023. Horizon Databook has segmented the China next-generation sequencing data analysis market based on services, ngs commercial software covering the revenue growth of each sub-segment from 2018 to 2030.
The China NGS data analysis market is driven by several initiatives undertaken by the Chinese companies to expand the NGS landscape. Companies such as Novo gene in Beijing have large sequencing capacities that can sequence genomes of 1 million beings all at once.
The Beijing Genomics Institute (BGI) in China is a key body in the global genomic sequencing industry. Due to this, the NGS laboratory of BGI in Hong Kong is regarded as one of the high-capacity next-generation genome sequencing laboratories.
The confluence of these factors is expected to drive the adoption of NGS data analysis software in China. The healthcare system in China is witnessing substantial demand for NGS technologies for chronic conditions.
Horizon Databook provides a detailed overview of country-level data and insights on the China next-generation sequencing data analysis market , including forecasts for subscribers. This country databook contains high-level insights into China next-generation sequencing data analysis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account